GENE ONLINE|News &
Opinion
Blog

Tulip Chakraborty

WRITTEN BY Tulip Chakraborty

Alnylam’s RNAi-Based Therapy Lumasiran Impresses in Phase 3 Primary Hyperoxaluria Trials
2020-06-12
Novartis’ Axial Spondyloarthritis Drug, Cosentyx Shines in Phase 3 Study
2020-06-08
ASCO 2020: Celyad’s Off the Shelf CAR-T Cell Therapy Shows Promise against Colorectal Cancer
2020-06-07
ASCO 2020: Genentech’s Novel anti-TIGIT Therapy Shows Promise in Phase II Lung Cancer Trials
2020-05-31
ASCO 2020: Results from the INFORM Registry, A Step Towards Personalized Therapy in Pediatric Cancer
2020-05-29
Novartis’ Kisqali Shows Promising Results in Advanced Breast Cancer Patients with Liver Metastases
2020-05-28
COVID-19: AstraZeneca Receives $1B from BARDA to Develop Oxford’s Coronavirus Vaccine
2020-05-23
Roche’s Tecentriq Bags Landmark FDA Approval as First-Line Monotherapy for Metastatic NSCLC
2020-05-20
Enhertu, AstraZeneca’s Drug against Gastric Cancer Gets Breakthrough Therapy Designation
2020-05-14
Rebiotix, Ferring Announces Positive Phase 3 Data of World’s First Microbiome-Based Therapeutic
2020-05-09
AACR 2020: Modifications in Tumor Microenvironment and Host Microbiome, a Potential Therapeutic Strategy for Immunotherapy
2020-05-08
Human Monoclonal Antibody Breakthroughs Provide New Hope against COVID-19
2020-05-06
AACR 2020: Targeting the KRAS Pathway – Old Protein, New Approaches
2020-04-30
AACR 2020 Conference – Recent Advances in Breast Cancer Treatments
2020-04-29
CAR-T Therapy – a Boon for Cancer Treatment?
2020-04-27
1 … 5 6 7 8
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top